New York, United States
Powerful Medical, founded in 2019, is spearheading transformation in the cardiovascular care sector through its pioneering use of artificial intelligence. Its flagship product, PMcardio®, leverages deep learning to enhance the diagnostic capabilities for cardiovascular diseases, a substantial challenge for the healthcare industry.
The core strength of PMcardio® lies in its algorithms, trained with over one million ECG records, allowing it to identify 38 different cardiac conditions from a single 12-lead ECG tracing. Statistically validated against clinician benchmarks, it shows measurable improvement in diagnostic performance across standard metrics.
As a CE-certified class IIb medical device, PMcardio offers mobility and accessibility on any smartphone, aligning with modern healthcare's trend toward digital solutions. With presence in New York, Aalst, and Bratislava, the firm employs over 50 professionals.
Recently, Powerful Medical secured a €2.50M grant from the European Innovation Council, underscoring investor confidence in its disruptive potential within the intersection of AI, Big Data, and Health Care.
VectraCor